Article in Clinical and translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Irene González-TorrentClinical and Translational Research in Cardiology Unit, Health Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
Carlota BenedictoClinical and Translational Research in Cardiology Unit, Health Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
Marta Delgado-ArijaClinical and Translational Research in Cardiology Unit, Health Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
Lorena Pérez-CarrilloClinical and Translational Research in Cardiology Unit, Health Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
Isaac Giménez-EscamillaClinical and Translational Research in Cardiology Unit, Health Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
Estefanía TarazónClinical and Translational Research in Cardiology Unit, Health Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
Esther Roselló-LletíClinical and Translational Research in Cardiology Unit, Health Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
Funding
Conselleria de Educación, Universidades y Empleo CIAICO/2022/246European UnionEuropean Union "Next Generation EU"Miguel Servet CP21/00041Miguel Servet FI21/00034Miguel Servet FI21/00186Ministry of Science and Innovation 10.13039/501100011033National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" PI20/00071National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" PI24/00088National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" PI24/01310State Investigation Agency CNS2022-135769State Investigation Agency CNS2024-1544396the European Recovery, Transformation and Resilience Plan (PRTR)
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A novel integrated miRNA-donor age signature enables detection of cardiac allograft vasculopathy. · full record | OpenQuestion